Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis
WebcastFaculty
OVERVIEW
Clinical Updates on Disease Modifying Therapies to Improve Outcomes for Patients with Multiple Sclerosis is organized by Academic CME and will be held during Jan 12, 2018 - Jan 11, 2019.
The target audience for this medical event is designed to meet the educational needs of neurologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with multiple sclerosis. This CME conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Course Description:
This educational activity will feature content presented at MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease-modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review how to implement recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes. Upon completion of this activity, learners will gain a better understanding of recent clinical trial data for the treatment of multiple sclerosis, ultimately improving patient outcomes.
Objectives:
Upon completion of this activity, participants will be better able to do the following:
• Identify recent prognosis and diagnostic strategies of multiple sclerosis.
• Review clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting.
• Incorporate recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes.
Additional details will be posted as soon as they are available.
The target audience for this medical event is designed to meet the educational needs of neurologists, and other healthcare professionals responsible for the diagnosis, treatment or management of patients with multiple sclerosis. This CME conference has been approved for a maximum of 1.00 AMA PRA Category 1 Credits.
Course Description:
This educational activity will feature content presented at MS Paris 2017 7th Joint ECTRIMS-ACTRIMS Meeting in Paris, France. Four expert faculty will examine recent prognosis and diagnostic strategies of multiple sclerosis. An analysis of clinical trial data of current and emerging disease-modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting will be discussed. The faculty will also review how to implement recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes. Upon completion of this activity, learners will gain a better understanding of recent clinical trial data for the treatment of multiple sclerosis, ultimately improving patient outcomes.
Objectives:
Upon completion of this activity, participants will be better able to do the following:
• Identify recent prognosis and diagnostic strategies of multiple sclerosis.
• Review clinical trial data of current and emerging disease modifying therapies as presented at the Joint ACTRIMS-ECTRIMS meeting.
• Incorporate recent scientific data to safely manage patients with multiple sclerosis for optimal outcomes.
Additional details will be posted as soon as they are available.
SPECIALITIES
Neurology
Quick Links